Medtronic Keeps Capturing High-Growth Markets: Time to Buy MDT Stock?

The past month has been quite encouraging for Medtronic (MDT) investors. Solid first-quarter fiscal 2025 organic growth performance and several strategic initiatives to revamp the bottom line, including the COGS cost-out programs, while maintaining pricing and maximizing efficiencies, seem to have boosted market sentiment.Added to this, growing optimism surrounding the Fed’s approach toward an imminent rate cut in September acts as a strong impetus in driving the stock price. All these have nullified the on ...